Home LiteratureArticle Details
PMID: 1033050 Published · ppublish English Journal Article

Genetic study of amobarbital elimination based on its kinetics in twins.

Clinical pharmacology and therapeutics ·Vol. 20 ·No. 6 ·1976-12-00 ·Pages 701-14

Endrenyi L, Inaba T, Kalow W

Abstract

Following the intravenous administration of 125 mg amobarbital sodium in 7 pairs of dizygotic and 7 pairs of monozygotic twins, the time-course of plasma concentrations was observed. The number of detectable compartments varied from subject to subject but was consistently 1 or 2 or 3 within a given individual. The terminal slope of the semilogarithmic concentration-time plot (corresponding to biologic half-life of 22.8 hr) did not represent the elimination rate constant even in persons with apparently single-compartmental characteristics. The redistribution of amobarbital was rapid in comparison with its elimination. The rate of the latter (characterized by kel = 0.051 hr-1, plasma clearance = 37.7 ml/min) could be closely identified with the rate of metabolism. The twin data showed that genetic control was exerted on kinetic parameters characterizing the rate of amobarbital elimination and, therfore, the rate of its metabolism. Correlation analysis suggested that this control was independent of size factors, which were themselves substantially heritable. The genetic analysis of twin data included, in addition to intracelass correlations and Holzinger's H factors, newly developed lower (and upper) bounds of the broad-sense heritability. In pharmacogenetic studies, assessment of model-independent kinetic parameters, such as plasma clearance with or without adjustment for body weight, is recommended.

MeSH Terms
Administration, Oral Adolescent Adult Amobarbital/administration & dosage,blood Female Half-Life Humans Injections, Intravenous Kinetics Male Metabolic Clearance Rate Middle Aged Models, Biological Pharmacogenetics Pregnancy Twins Twins, Dizygotic Twins, Monozygotic
Chemicals
Amobarbital
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Endrenyi L
Inaba T
Kalow W
Article Info
Journal
Clinical pharmacology and therapeutics
Abbr.
Clin Pharmacol Ther
ISSN
0009-9236
Published
1976-12-00
Pages
701-14
Language
English
Region
United States
NLM ID
0372741
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com